Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY)

por Horga, Arantxa, Saenz, Rebecca, Yilmaz, Gürdal, Simón-Campos, Abraham, Pietropaolo, Keith, Stubbings, William J, Collinson, Neil, Ishak, Laura, Zrinscak, Barbara, Belanger, Bruce, Granier, Catherine, Lin, Kai, C Hurt, Aeron, Zhou, Xiao-Jian, Wildum, Steffen, Hammond, Janet
Publicado 2023